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A B S T R A C T
Elite athletes face extreme challenges to perform at peak levels. Acute and chronic musculoskeletal injuries are
an occupational hazard while pressures to return to play post-injury are commonplace. Therapeutic options
available to elite athletes range from novel ‘cutting edge’ biomedical therapies, established biomedical and
surgical techniques, and physiotherapy, to a variety of non-orthodox therapies. Little is known about how dif-
ferent treatment options are selected, evaluated, nor how their uses are negotiated in practice.
We draw on data from interviews with 27 leading sports medicine physicians working in professional football
and cycling in the UK, collected 2014–16. Using idea of the ‘therapeutic landscape’ as a conceptual frame, we
discuss how non-orthodox tools, technologies and/or techniques enter the therapeutic landscape of elite sports
medicine, and how the boundaries between orthodox and non-orthodox therapy are conceptualised and navi-
gated by sports medicine practitioners.
The data provide a detailed and nuanced examination of heterogenous therapeutic decision –making, rea-
soning and practice. Our data show that although the biomedical paradigm remains dominant, a wide range of
non-orthodox therapies are frequently used, or authorised for use, by sports medicine practitioners, and this is
achieved in complex and contested ways. Moreover, we situate debates around nonorthodox medicine practices
in elite sports in ways that critically inform current theories on Complementary and Alternative Medicine
(CAM)/biomedicine. We argue that existing theoretical concepts of medical pluralism, integration, diversity and
hybridisation, which are used to explain CAMs through their relationships with biomedicine, do not adequately
account for the multiplicity, complexity and contestation that characterise contemporary forms of CAM use in
elite sport.
1. Introduction
The use of non-orthodox therapies by athletes is prevalent across the
globe (Carter, 2010; Pike, 2005; Theberge, 2008; Bundon and Hurd
Clarke, 2014; Yang et al., 2016). Healthcare professionals working with
elite athletes tend to have access to a global healthcare market and are
not therefore constrained by state sanctioned therapeutic approaches
(Faulkner et al., 2017). This, added to the highly unusual set of pres-
sures sports medicine practitioners face to repair injured bodies
(Kimmerle et al., 2012), makes it an area ripe for exploration. However,
issues around when, why, and how non-orthodox therapies are utilised
in the context of the profession of sports medicine have been neglected
in the social sciences.
Unorthodox medical practices co-exist alongside biomedicine and
even thrive in some areas such as football medicine (Carter, 2010;
Faulkner et al., 2017; McNamee et al., 2018). Previous studies focusing
on athletes indicate that non-orthodox therapies are used for a variety
of interconnected reasons such as recovery from prolonged periods of
injury or illness, and/or dissatisfaction with the perceived inadequacy
of orthodox biomedical care, and/or pressure to accelerate return to
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play, and to enhance performance (Faulkner et al., 2017; Kimmerle
et al., 2012; Pike, 2005; Theberge, 2008). The specific cultural contexts
of care can also be an important factor influencing which therapeutic
approaches are taken by athletes and to what degree (Yang et al.,
2016). The popularity of Complementary and Alternative Medicine
(CAM) among teammates and their availability within sports clubs can
act to normalize their use (Bundon and Hurd Clarke, 2014). The ma-
jority of this research has sought to understand CAM use from athlete –
patient perspectives. Yet, little is known about how sports medicine
practitioners engage with the non-orthodox therapies and healing
strategies that they encounter in their everyday practice. Equally ob-
scure are the rationales for different treatment options: how they are
selected, evaluated, negotiated and combined into therapeutic regimens
within the landscape of elite sports medicine, where a plurality of
therapeutic options exists.
The aim of this paper is to investigate how therapeutic decisions are
made, in contexts where multiple healing systems are utilised to
manage injury. We develop new ways of thinking about CAM that
challenge the orthodox/non-orthodox distinction. We begin by out-
lining prevailing understandings of orthodox/non-orthodoxy in medi-
cine. We discuss key social scientific concepts of “medical pluralism”,
“integration”, “diversity” and “hybridisation” that have been applied to
theorize different forms of healing systems and practices available to us,
and the relationships between them. We propose that the concept of
‘therapeutic landscape’ although broader and more loosely defined than
the foregoing concepts, is better placed to account for contemporary
forms of CAM use and the porous boundaries we observe between
different therapeutic approaches, tools, technologies and techniques in
clinical practice.
1.1. (Non)orthodox medicine
Biomedicine, with its focus on the biological body and tech-
noscientific practices of healing and repair (Clarke et al., 2010), is the
dominant form of medical knowledge and practice across the developed
world. Other systems of healing and therapy tend to fall under the
broad umbrella of CAM. CAM therapies are based on divergent theories
about the body, the causes of illness and mechanisms of healing. Thus,
the CAM label can encompass a wide range of therapeutic approaches,
products and practices, from acupuncture, homeopathy and herbal
medicine to massage, reflexology and hypnotherapy. Some classifica-
tions also include prayer and spiritual healing (Ayers and Kronenfeld,
2010). CAM therapies may also be referred to as ‘non-orthodox’ to re-
flect their subordinate relationship with biomedicine as the orthodox or
hegemonic form of medical knowledge in Western societies (Cant,
2009; Saks, 2015). Thus, references to non-orthodox healthcare could
also encompass a wider range of technologies, techniques and practices
than listed above – such as novel yet scientifically unproven medical
therapeutics and surgical techniques, nutritional supplements and other
foodstuffs as well as commercially available health tests and diagnostic
devices.
Osteopathy and chiropractic notwithstanding, there is no profes-
sional statutory regulation of CAM treatments in the UK (Saks, 2015).
Consequently, many non-orthodox therapies are unregulated. Lack of
state endorsement is another means by which orthodox and non-or-
thodox medicine are bifurcated (Saks, 2003), as biomedical approaches
dominate provision via National Health Care systems, with CAM often
regarded as an “individual consumptive choice” (Ning, 2018). Ad-
ditionally, non-orthodox therapies can be demarcated from orthodox
medicine based on lack of an established scientific evidence base for
their utility, safety or efficacy. Nevertheless, there are notable excep-
tions such as acupuncture, which has been the subject of randomised
controlled trials with an emerging scientific evidence base for its effi-
cacy in pain management. The existence of (at least some) scientific
evidence assists in the legitimation process of complementary medicine
within the dominant biomedical paradigm, but also contributes to the
blurring of what constitutes biomedicine and its alternatives (Polich
et al., 2010). Despite the dominance of the paradigm, the boundaries
between perceptions of legitimate biomedical therapies and non-or-
thodox ones are fluid, shifting in response to developments in culture,
values, knowledge and practice, and are subject to challenge (Naraindas
et al., 2014).
1.2. CAM theory
Several different concepts can help us to understand the use of non-
orthodox therapies in relation to biomedicine. Undoubtedly, the most
well known of these is medical pluralism or pluralisation –which can be
used to explain how multiple and distinct healing modalities and sys-
tems of knowledge exist simultaneously and can be chosen as alter-
natives to one another (Cant and Sharma, 1999). The concept has been
fruitful in furthering our understanding of variability of healing prac-
tices and contexts. Never-the-less, empirical studies have shown how
processes of pluralisation are messy in practice; divergent therapies are
often not selected as alternatives to one another, nor as alternatives to
biomedicine, but rather used in combination. The notion that in-
dividuals choose between competing systems is simplistic.
Our understanding of medical pluralisation, specifically in relation
to CAM and biomedicine, has been advanced through the concept of
‘integration’. Typically this is through the assimilation of CAM into
biomedical healthcare regimens, the mechanisms through which it is
managed, and the relationships clinicians have with CAM care (Broom
and Tovey, 2007; Cant et al., 2011; García-Escamilla et al., 2016).
Within this conceptualization, non-orthodox therapies are character-
istically viewed as ‘complementary’ to biomedical regimes, while re-
maining under the control of orthodox healthcare practitioners (Wiese
et al., 2010). One important criticism of this configuration stems from
Science and Technology Studies where a sustained body of scholarship
has shown how biomedicine is not homogeneous, but is better viewed
as multiple, fragmented, fluid, and contested (Mol, 2002). Therefore,
holding biomedicine and its alternatives up as two discrete entities
represents a false dichotomy (Hsu, 2008; Ning, 2013). Consequently,
within sociology, it is now more common to conceptualise healing
practices in terms of diversity (Parkin, 2013) which accounts for bor-
rowing and exchange between different medical systems of knowledge
and practice - or hybridity (Dew et al., 2014) – to capture the diverse
ways through which healing practices are assembled by users in the
search for effective remedies or symptom management (Thomas and
Coleman, 2004).
Our analysis of the CAM literature, therefore, yields a conceptual
typology spanning the separate alternatives of pluralisation on one
hand to the ‘mix and match’ of hybridity/diversity on the other. The
typology is useful in being more specific than the well-known concept
of ‘medical pluralism’ per se (e.g. Cant, 2009) that elides these dis-
tinctions.
In addition, theoretical developments in medical anthropology also
move beyond this conceptual frame. For example, Hörbst and Wolf
(2014) propose the concept of ‘medicoscapes’ to account for the blur-
ring of medical cultures in an increasingly globalised world, and the
ways in which knowledges, artefacts and practices together with asso-
ciated policies and power relations come together in local contexts.
Relatedly, Hsu (2008) introduces the idea of ‘medical landscapes’ as
way to conceptualise medical pluralism beyond the view of medical
cultures as clearly bounded entities centred around a culturally adept
healer. Instead, she proposes that, in thinking more broadly about the
medical landscape and its contours and features, we might con-
ceptualise how particular configurations of people, objects and
knowledge, along with their social, economic and political entangle-
ments, come together in a specific locale.
Our aim throughout this paper is to attend to therapeutic decision
-making, therapeutic reasoning and therapeutic practices developed by
sports medicine practitioners in the context of elite sport injury.
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Building on anthropological concepts of ‘medicoscapes’ (Hörbst and
Wolf, 2014) and ‘medical landscapes’ (Hsu, 2008) and bringing this
together with work on boundaries between orthodox and non-orthodox
medicine (Ning, 2013; Ning, 2018; Naraindas et al., 2014), our analysis
in this paper develops the idea of ‘therapeutic landscapes’.
The therapeutic landscape concept has its roots in health geography
where it is typically applied to study how certain physical places come
to be perceived and experienced as therapeutic, emphasising the con-
nection between environment and health (Gesler, 1992). The concept is
widely regarded as a useful heuristic to better understand the ‘char-
acteristics of place’ and how these contribute towards making places
and spaces health-enabling as in, for example, green spaces, hospital
wards and everyday places such as the home as sites of healing (Bell
et al., 2018). Since its original articulation, the concept has developed
significantly within medical geography to “examine how therapeutic
places and spaces work … to maintain and promote health and well-
being for different individuals and groups at different times” (Bell et al.,
2018; p7). Bell et al. (2018) also note the potential value of the concept
in accounting for cross-cultural differences in the expectations, norms,
narratives and understandings of health and wellbeing, and how these
can shape one's affective experiences of particular spaces.
Beyond health geography, the concept has been applied in different
fields including sociology, the arts, nursing, anthropology and ger-
ontology (Bell et al., 2018; Cutchin et al., 2010). In sociology, a small
number of studies have applied this concept to analyse physical spaces
of healing, for example healthcare buildings (Martin et al., 2015), as
well as the role of relational networks and notions of pluralism within
these landscapes of healing (Van Ingen, 2004). In their study on breast
cancer patients, English et al. (2008) explore how different environ-
ments contribute to the healing process and can act to shape experi-
ences of healing. Their work identifies multiple ‘landscapes of healing’ –
the individual body, the home, local communities, interactions with
friends, natural environments as well as locations of formal and alter-
native healthcare - demonstrating how these physical and relational
landscapes interact and overlap in recovery from illness.
Following Hsu (2008) we argue that the landscape metaphor is a
useful way to think about medicine and healthcare and gives us a tool
to conceptualise how configurations of people, objects and knowledge,
along with their social, economic and political entanglements, come
together and operate together in a specific locale. Inspired by work in
medical sociology on therapeutic plurality (Broom and Tovey, 2007)
and in medical anthropology on medicoscapes (Hörbst and Wolf, 2014)
medical landscapes (Hsu, 2008) and the porous boundaries between
orthodox and non-orthodox medicine (Ning, 2013; Ning, 2018;
Naraindas et al., 2014), we propose to develop the concept of ther-
apeutic landscapes further for application within medical sociology. To
do this, we propose a shift in focus away from ‘place’ to ‘space’ and
further towards the networks of things, people, knowledge and so on,
that come together in particular spaces and places to impact on health
and healing. Following Gieryn (2000), Martin et al. (2015) argue that
“place becomes space when it is filled up by people, practices, objects
and representations”. In doing so we present a more robust definition of
therapeutic landscapes for medical sociology as spaces where multiple
healing knowledges, therapies, artefacts, symbols, practices and people can
come together and interact in various and shifting ways.
Instead of focusing on ‘medicine’, one particular therapy or set of
relationships, the vantage point we have taken allows us to explore
therapeutic decision-making, therapeutic reasoning and use in practice
in regard to multiple therapies and therapeutic approaches that span
the orthodox/non-orthodox divide.
Specifically, framing our research questions in terms of the ther-
apeutic landscape as discussed above, we ask:
1. What factors influence elite sports medicine practitioner's decisions
to use non- orthodox therapies in the treatment of sports injuries?;
2. How are the boundaries between orthodox and non-orthodox
therapy conceptualised by sports medicine practitioners?; and
3. How are non-orthodox therapies being used in practice?
2. Methods and data collection
Data are drawn from in-depth qualitative interviews with 27 leading
sports medicine practitioners (9 medical doctors, 11 physiotherapists
and 7 orthopaedic surgeons) with experience of working in elite foot-
ball and cycling in the UK. These were collected as part of a larger study
which set out to examine the intersections between medicine, tech-
nology and elite sport, and were conducted between 2014 and 2016.
Ethical approval was obtained from the University of Sussex, UK.
We focus on elite football and cycling as these are two sports or-
ganised in very different ways. Elite football is overwhelmingly pri-
vately funded whereas cycling is supported through public finance to-
gether with some private funding in the UK, a key difference that
impacts upon the nature and composition of medical teams. Both sports
have high public visibility, prominence of musculoskeletal injuries, and
dominance of biomedicine (See Faulkner et al., 2017). Sports medicine
practitioners often work across different sports and relate to ‘sports
medicine’ as a specialty, hence we mainly refer to ‘elite sports medicine’
rather than cycling medicine or football medicine. We focus specifically
on the management of musculoskeletal injuries within these sports.
Musculoskeletal injuries are prominent amongst high performance
sports players (Jacobsson et al., 2013) and therefore a topic all of our
participants were experienced in managing and able to talk about with
ease. We selected participants on the basis that they: (a) were or had
previously been a core member of a medical team in elite football or
cycling in the UK; or (b) had experience of treating musculoskeletal
injuries incurred by elite footballers and/or cyclists; or (c) were medical
officers in sports governing bodies/other sports specific organisations,
with particular interests in football and cycling.
Semi-structured interviews were carried out by one or more of the
research team at a place of the interviewee's choosing. Topics covered
included views on particular novel and established treatments for
musculoskeletal injuries, including specific treatment pathways for
particular injuries and informal healing practices that they considered
or were engaged in. Interviews lasted for an hour on average and were
audio recorded and transcribed. Analysis of the transcripts was fa-
cilitated using the qualitative data analysis software package NVivo. We
took an inductive thematic approach to data analysis (Braun and
Clarke, 2012) which involved reading and re-reading the transcripts,
grouping data extracts together based on their main topics and issues,
developing a coding frame based on these and connecting congruent
codes together to generate themes based on patterns of meaning across
the dataset. We developed an interpretative analysis of views and ex-
periences of non-orthodox healing practices, and accounts of medical
decision - making and discussed these in relation to broader theoretical
and conceptual issues outlined earlier.
Next we discuss some of the factors influencing elite sports medicine
practitioner's decisions to use non- orthodox therapies in the treatment
of sports injuries. Our data illustrate the porous boundaries between
CAM and biomedicine in elite sports. We argue that non-orthodox
therapies are viewed as credible therapeutic options for injuries in
multiple ways that cannot be easily accounted for by any single model
of the CAM/orthodox medicine relationship.
3. Findings
Our data indicate that a wide spectrum of therapies and practices
for treating musculoskeletal injuries fall within the therapeutic land-
scape of sports medicine. The sports medicine practitioners we inter-
viewed discussed established biomedical and surgical techniques, novel
biological therapeutics, ‘exercise as medicine’ (including yoga), phy-
siotherapy techniques such as deep tissue massage, hydrotherapy and
heat/ice treatments. Additionally, they spoke about a large number of
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treatments, techniques and/or healing approaches that could be cate-
gorized as non-orthodox therapies. These included: acupuncture, elec-
trical stimulation (EPI), chiropractic, cupping, homeopathy, injections
of animal blood products (actovegin and placenta treatments), osteo-
pathy, ozone therapy, prolotherapy, reflexology, reiki and forms of
traditional and spiritual healing. It is how sports medicine practitioners
engage with this latter group of therapies that is the focus of our ana-
lysis. In what follows, we analyse (1) the treatment decisions (2)
therapeutic reasoning and (3) therapeutic practices developed by sports
medicine practitioners within the therapeutic landscapes of elite sports
medicine. Specifically, we pay critical attention to how the boundaries
between CAMs and biomedicine are conceptualised and upheld and
transgressed.
3.1. Therapeutic decision –making: trends, friends and influences
One of the pervasive means by which non-orthodox therapies can
come into the field of elite sports medicine is as fads and fashions. These
are often led by charismatic practitioners or ‘gurus’ who make a name
for themselves in a particular sport or country by treating high profile
athletes with a novel therapy or approach and gaining media coverage
of their apparent successes.
An example is in the use of animal blood products - in the form of
Actovegin (made from an ultra-filtrated extract of calf's blood) or horse
placenta - as treatments for muscle injuries and/or as a way to accel-
erate healing. These were prevalent, albeit controversial, potential
therapies discussed by participants. Both can be considered unorthodox
given their limited scientific evidence base, and both are unlicensed and
unregulated. Treatment protocols for these therapies are veiled in se-
crecy and evidence for efficacy is typically presented in the form of
individual testimonies (often from high profile athletes) and unverified
case studies. The use of these two therapies can be linked to specific
individuals who have attained a guru-like status within sports medi-
cine, popularising their therapeutic approach, which promises a speedy
recovery from injury and return to play. Actovegin was popularised by
the German sports doctor Dr. Hans-Wilhelm Muller-Wohlfahrt, Team
Physician for the German Football National Team and Bayern Munich
football club, while Serbian physiotherapist Mariana Kovacevic has
become known as the ‘placenta doctor’ in the British press after re-
portedly treating a string of high profile professional football players.
The charisma of the practitioner, the power of their personality and
their ability to connect with athlete-patients and give them hope were
all discussed as important factors contributing to the practitioner and
the therapies' popularity.
Several of our participants said that they did or had used Actovegin
to treat muscle strains or hamstring injuries, and a number of these
individuals had had direct contact with Muller-Wohlfahrt. All were
either physiotherapists or sports doctors working within elite football.
For example:
In terms of Actovegin […] I ran a workshop about four or five years ago
where we got some leading practitioners, for example, Muller- Wohlfahrt
from Germany, who was the pioneer of this work, came over and spent
two days with us to talk about what he does […]he was a fascinating
person in that, I suppose there was a lot of artistry, a lot of, kind of,
personal believe in there. […] It seemed very out there as what you might
call a ‘mainstream’, whatever that is, practice. (I27, Medical doctor)
Others, by contrast had either not heard of the substance or did not
have access to it:
Actovegin - never used because I haven't been able to get hold of it. (I23,
Medical doctor)
Of particular significance was the importance given by our re-
spondents to the athlete-patient's views and their belief systems in
therapeutic decision-making. It was apparent that athlete-patients are
considered to be important assets, and that they have a voice that is
heard in the therapeutic encounter (Theberge, 2008). As a phy-
siotherapist explains in the data extract below, often athlete –patients
request particular therapies, sometimes they have tried these before
and had success, other times preference for therapies is linked to cul-
tural belief systems to do with healing and performance:
If I want to, say, manipulate a player's neck and culturally he does not
believe in it and it isn't accepted, come hell or high water you're not going
to make him right […] Players come in, some hate it “I don't want
acupuncture; no, this is what I need; I definitely need this …” so, we
listen to it […] (I12, Physiotherapist)
In sports medicine, medical teams are typically multidisciplinary
and can include sports physicians, physiotherapists, orthopaedic sur-
geons, and physiologists, ‘alternative’ practitioners such as chir-
opractors and osteopaths as well as ‘non-professionals’ such as trainers
and masseurs. In our study it was always a physiotherapist or medical
doctor leading the team although others could be included in the de-
cision making process for particular injuries (eg. Orthopaedic surgeons)
or for specific patients (e.g. reflexologists, chiropractors). As can be
seen in the next data extract, it was often the case that someone within
the local network – maybe a coach or perhaps an athlete-patient
themselves - has seen or heard of a novel or non-orthodox therapy or
practitioner via one of their contacts in the wider network and sug-
gested this for a specific athlete-patient:
You're kind of gathering evidence from different sources, and certain
doctors, physios, sports scientists […] Sometimes the players will come to
in […] “I'm doing this because my mate's done this and I think this is
great.” Or the coaches will for instance say, “I really want this player
back. I know my mate at such and such a club has been using this ma-
chine on all his players and I want you to use this.” (I10, Medical doctor)
Within these networks, the strongest influence on therapeutic de-
cision making might come from one particular practitioner, influenced
by their professional background and training. Nevertheless, it was
apparent how, therapeutic decisions were often influenced from a range
of healthcare, and non-healthcare actors. On occasions even the views
of managers, agents, coaches, sports scientists, trainers, and sometimes
parents (for younger athlete-patients) contributed to therapeutic deci-
sion – making though in the elite levels of football at least, there is
survey evidence that managers and coaches have less influence than
they used to (Malcolm et al, 2015).
3.2. Therapeutic reasoning: epistemology and ‘evidentiality’
Our participants readily acknowledged that many therapies they
used could be classed as novel, non- orthodox or ‘not mainstream’. A
small number of participants expressed openness to alternative epis-
temologies of healing, acknowledging that ‘medicine is not a precise
science’ (I7) and that it is not always necessary to know how something
works, it is enough that it does work:
I've often said why does it need to be peer reviewed literature, and ac-
tually be proven in a research study to say it's working. I know it's
working. My players are feeling better […] there's techniques out there
like Bowen Technique, there's Reiki, all these kinds of techniques that are
out there, that people are doing through alternative medicine that are
having good results with their clients. And there is no reason why they
can't be used in a football setting. (I4, Physiotherapist)
However, for most, which is likely a reflection of their professional
backgrounds and hierarchies, biomedicine retained its hegemonic
status. Consequently, some of the healing techniques or approaches
(e.g. Osteopathy, Chiropractic) were referred to as ‘fringe’ therapies and
non-orthodox therapies tended to be ‘othered’ in relation to biomedi-
cine. We can see in our data how, conceptually speaking, these thera-
pies were demarcated from biomedical therapies, usually with some
discussion of their scientific evidence base, or lack thereof:
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Prolotherapy [is] often championed by sort of osteopaths and the chir-
opractors, a group who are not particularly well known for their clinical
reasoning and scientific, evidence-based practice. And I think phy-
siotherapy as a body are quite prepared to admit that a lot of what they
do is not evidence-based practice […] but they are embracing evidence-
based practice with a vengeance and there's a lot of pressure for the CSP
(Chartered Society of Physiotherapists) to kick out craniosacral osteo-
pathy and those sort of things. (I25, Orthopaedic surgeon)
One of the main reasons practitioners gave for not using (particular)
non-orthodox therapies was lack of scientific evidence base for their
utility. The absence of scientific evidence was used to bifurcate non-
orthodox from orthodox (or ‘evidence based medicine’) techniques or
practices, at the same time marking those without an evidence base as
‘risky’. This was not only so in regard to potential health and perfor-
mance deficits, but also in terms of reputational damage:
I can remember a few years ago that extraordinary woman from the
Eastern Bloc doing the placenta stuff. Now, are you willing to risk an £80
million player with that sort of technology that has no basis of any evi-
dence at all and, with all the other ramifications that would be in-
troduced, you know, she's doing it in a block of flats in an Eastern Bloc
country with no sterile environment […] you let all your players do all
these weird and wonderful things, you're opening yourself up to ridicule
really. (I6, Physiotherapist)
Interestingly, for others, allusion to the ‘evidence’ for a particular
therapy amounted to an assertion that a scientific evidence base is
emerging for the therapeutic modality. Indeed, participants described
how they were or had been involved in scientific research on specific
therapies in an elite sport population (e.g. Actovegin, Acupuncture,
shockwave therapy) in attempts to align their use of a particular
therapy with a scientific paradigm, thus blurring the boundaries be-
tween biomedicine and its alternatives. A clear example is shown below
where a physiotherapist is talking about how they attempted to build an
evidence base to justify integration of Actovegin into their therapeutic
practice:
I4: We did a study [which] showed that we were drastically reducing the
amount of time lost for [specific injuries] using Actovegin […] anybody
who has a [specific injury] we tend to use, doesn't matter whether it's one
of the young pros or whether it's one of the senior pros … his wages
would not affect that decision on that.Interviewer: And that expresses the
confidence you have in it? I4: Yes. (14, Physiotherapist)
Scientific evidence then can become an indicator of ‘objectivity’, an
apparatus of governance that is used to confer legitimacy to the mod-
ality. For others, however, the lack of scientific research within an elite
sports population was not considered problematic. Participants dis-
cussed the difficulties of conducting largescale studies within the elite
athlete population. Doubts were raised whether large scale randomised
controlled trials on non-athletic populations would effectively translate.
Some were firmly of the opinion that in relation to elite sports, athletes
were viewed as unique and extraordinary individuals, thus warranting
an individual therapeutic approach. This can be seen the quotation
below where the sports doctor adopts an integrated biomedical and
homeopathic therapeutic regimen, justifying this through the unique-
ness of the individual, thereby rendering the lack of scientific evidence
for its use somewhat inconsequential. It is noteworthy that despite
sanctioning and administering the therapy, the doctor still questions its
physiological efficacy:
Traumeel I have used, particularly on a player who came to me who said,
“I've got a minor muscle injury, can I have some Traumeel?” He'd had it
before, he believed in it. I used to use it with him relatively regularly when
he had grade one muscle injuries and he wanted to play with them. But
interestingly, he'd had it mixed with a local anaesthetic and what I think
he was doing was not feeling the small percentage of his muscle that was
a problem […] He's physiologically a very strange individual. I wouldn't
use it on anybody else. (I23, Medical doctor)
Yet, as our participants reminded us, evidence-based medicine is not
comprised exclusively of randomised controlled trials, but also includes
clinical judgement. In this regard, there is space for alternative forms of
evidence to emerge, and to be valued, including recommendations and
testimonies from other practitioners in the field, as well as clinician's
own observations and experiences. For instance, our interviewees fre-
quently told us how upon hearing of the successes of a particular novel
non-orthodox therapy, would contact the practitioner, observe their
practice and share in their knowledge, often taking this as a base for
their own experimentation. Thus, clinical expertise is built from ex-
periential knowledge about what works for a particular type of patient
and their injury. A result of this is that some sports, teams or clubs will
end up using a particular therapy (or combinations of therapies) that
they have found works for their patients despite a lack of scientific
evidence for efficacy, whereas others have found no benefit and do not
use it. Indeed, this aligns with other studies on CAMs which have found
that clinical testimony of positive benefit to patients is a cornerstone of
legitimacy when scientific evidence is lacking (Willis and White, 2017).
We can see, then, what have been termed ‘communities of practice’
(Wenger, 1998) – as in groups of people who share a common goal,
interacting with and learning from one another - operating within
sports medicine generally, and in the case of the examples above op-
erating on a more local level within sports medicine/healthcare teams.
3.3. Therapeutic practice: adapting, appeasing and controlling
A consequence of the seemingly ad hoc adoption and combination of
various therapeutic approaches influenced by athlete - patient belief
systems, cultures, peer networks and local pressures is the relative ab-
sence of standard protocols for how non-orthodox therapies should be
assimilated, incorporated or mixed into therapeutic regimes when
compared to other areas of medicine. Some practitioners described
taking an almost pluralistic approach (Cant and Sharma, 1999) turning
to specific therapies in cases of prolonged injury for example, when
orthodox medical approaches were lacking or so far ineffectual, where
others described adopting more of a mix and match approach where
several types of therapy could become ‘hybridised’ (Dew et al., 2014) in
clinical practice. It is interesting to note that pluralistic, integrative and
hybridised approaches to combining biomedicine and ‘CAM’ in clinical
practice were described across the dataset and were not mutually ex-
clusive of one another. Indeed, different approaches and rationales for
using particular non-orthodox therapies were given by the same prac-
titioner at different times.
Practitioners described their experimentation with various therapies
as ‘tinkering’ (I4) or ‘moulding and adapting’ (I12) their therapeutic
approach based on what was available, desirable and effective for the
patient and practitioner at a particular time. It was clear that being able
to offer multiple therapeutic options was important in the sports
medicine field for several reasons. For example, such use might allow
one to be seen as cutting edge; to make a name for oneself; or (crucially)
to be seen to be proactive and ‘doing something’ in order to appease
managers, athlete –patients, and agents, all of whom had various in-
terests in the athletes' return to play (RTP) decisions. Time pressures on
recovery mean that often there is the expectation that practitioners will
use every tool at their disposal to facilitate RTP. Therefore, pushing the
boundaries to enhance recovery time is routine healthcare in a way that
it is not seen in other areas of medical practice. In the extract below a
medical doctor who works with elite cyclists is talking about why he
began using Traumeel1 and when he might use it in his practice now:
1 Traumeel is a homeopathic remedy, originating in Germany. Despite lack of
consensus about its scientific evidence base it is a popular therapy and had been
used by almost a third of the practising sports physicians we interviewed.
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Traumeel was something in 2006, prior to (a) major games, that I was
aware I'd have to consider giving because it was being widespread ad-
ministered by Dr Müller-Wohlfahrt in Munich and at that stage many
athletes were going over to Munich to have these injections. I met him on
three occasions, and he told me he'd given over 10,000 injections of
Traumeel without a single side-effect. When I researched it, it's in
widespread use in Germany. It's not licensed in the UK. It's homeopathic,
so it's 1 in 10,000 dilutions, isn't it, so it's meant to contain a single atom
of arnica, calendula, Echinacea and various other herbs, …and I bought
some and experimented a little bit with it and had some extremely good
successes […] I'd seen them given by UK Athletics doctors and spoke to
doctors working in professional football before I did them myself and I
probably wouldn't use it more than once a year at the moment. I've got
one client I'm thinking of using it on at present, who's got lots of other
issues we've corrected, but she's getting recurrent calf tightness for no
obvious reason, despite multiple assessments, and if the latest plans don't
work, she's training, but just not able to compete at her absolute max-
imum, that's the sort of time I might consider using it. […] I would only
use it in elite sport, I would never use it in an NHS setting (I42, Medical
Doctor)
We can see in this case how therapeutic practice has been influenced
by trends in the global field of spots medicine as well as communities of
practice (Wenger, 1998) and personal networks (Nixon, 1993). Meeting
with the ‘guru’, watching their practice, in addition to the testimony of
others are taken as forms of evidence for its potential efficacy. More-
over, the lack of quick and effective biomedical treatments creates a
space for the non-orthodox therapy to be incorporated into therapeutic
regimens on an individual basis, driven by the focus of RTP.
It was common for practitioners to justify their stance of allowing,
enabling or offering access to a particular non-orthodox therapy on the
grounds that it would ‘not do any harm’ (nor violate anti-doping rules)
to the patient. Many spoke about the emotional impact of non-orthodox
therapies on the patient's recovery from injury, valuing these aspects of
the healing process. It is clear that optimal recovery from injury was
thought, importantly, to involve psychological as well as physical
health where even small gains in RTP or performance could translate
into big differences for elite athletes:
Some players like cupping for instance which I used to see those old-
fashioned glass cups in the museum at [Hospital] and thought “how can
anyone ever do that?” but cupping is not an unusual thing in clubs. […]
the difficulty is when you're talking about performance and sport ev-
eryone is looking for the small margin, for the minimal gain that you can
get to make a difference. So, therefore, you are going to experiment and
try anything in order to affect that, and most of that will be psycholo-
gical, of course, rather than physical. (I13, Medical Doctor)
The allure of marginal gains ties into the atypical goals of sports
medicine. We can see how healing can be decentred to make space for
‘performance’ (Kimmerle et al, 2012). The idea of ‘competition readi-
ness’ is at the forefront of clinical practice as the costs to clubs and
teams of athlete unavailability for selection is perceived to be high. In
the quote below a physiotherapist justifies the use of a reflexologist to
treat an athlete. We can see here how the different aspects of ther-
apeutic decision-making and reasoning come together in clinical prac-
tice. The global nature of sports medicine is evident, as well as the
influence of patient beliefs and role of non-medical staff in collective
therapeutic decision-making. Here pluralism justifies alternative op-
tions when orthodox care has failed:
You would be amazed what influences a player's recovery most […] We
had a top [European] player, believed heavily in reflexology. Reflexology
is a thing that at that time I wasn't that convinced did or didn't do
anything. But, he believed in it […] we were playing a major [tourna-
ment name] game and he picked up an injury […] he had no chance of
playing. And that night this guy flew in from [European country] to treat
him for two days. I was a young physiotherapist and I said to [the
manager] “I'm not happy about this, I think it's wrong” but he turned to
me he said “well, you've already told me he's got no chance with you, he
thinks he's got an opportunity with him.” (I7, Physiotherapist)
In these cases, non-orthodox therapies are often given a different
role to biomedicine in the healing process, but a valued one none-
theless, considering their potential benefits in delivering those revered
marginal gains in recovery and performance. It is interesting how the
psychological aspects of healing were also used in other ways, as part of
the craft of sports medicine. For instance, it was common for our par-
ticipants to talk about their use of non-orthodox therapies as a form of
control. For example, one physiotherapist talked about how they cre-
ated bespoke and ‘hybridised’ therapeutic regimens for patients influ-
enced by the latters' belief system, while also channelling all patients
into the same rehabilitation programmes. In their view, the value of
hybridising their therapeutic regime to incorporate non-orthodox
therapies is in terms of getting athlete patients to ‘buy in’ or ‘adhere’ to
biomedical treatment, rest and rehabilitation routines:
The same condition could be treated slightly differently but we then start
channelling them into the rehab programmes that are identical. So, on the
initial basis we say “okay, we will do your EPI [electrical stimulation]
but then you've got to do my work, right?” “Yes, fine, as long as I get my
EPI I'll do whatever you want”. We do that and then they slowly say
“hang on, your treatment actually works. I don't need the EPI anymore.”
(I12, Physiotherapist)
This view was shared by others who talked about using non-or-
thodox therapies as ‘distraction techniques’ or ‘space fillers’, ways to
keep the patient occupied, to appear proactive, to appease demands of
others, to be seen as doing something, whilst in reality securing time for
the healing process. In these instances biomedicine retains its hege-
monic position and CAM therapies, and the knowledge underpinning
them, are subordinated.
Another way this can occur is through the reactive use of non-or-
thodox therapies as a strategy to retain control over the therapeutic
regimen. In the contexts of elite sport medicine, the patient – practi-
tioner relationship is not top-down since the patient (and their agent)
might exercise considerable (economic) power. There is a constant
threat that if not satisfied with the care that they receive (often pro-
moted by their agent), athletes will go elsewhere to get the treatments
they believe will assist swifter RTP. Practitioners spoke about multiple
and heterogeneous therapeutic regimens within which they would offer
selected non-orthodox therapies ‘in house’, receive training to admin-
ister non-orthodox themselves (e.g. acupuncture) or bring in specialised
non-orthodox practitioners to provide a specific alternative therapy (e.g
reflexology, chiropractic) as a way to prevent their athlete patients from
seeking out alternative therapies in an uninformed way. As one parti-
cipant puts it:
If I have a player and I am offering him a treatment for something, in
some respects, what it does is it stops him going and getting a treatment
from somewhere else because he hasn't been offered it by me. And I
would rather control the degree of mismanagement. (I23, Medical
Doctor).
The role non-orthodox therapies play in therapeutic regimens is
therefore integral to the successful practice of sports medicine, even if
conceptually they may continue to be othered, regarded as useful ad-
juncts or ‘distractions’ but not alternatives to real biomedical treat-
ments, or rest for recovery.
4. Discussion: beyond the orthodox/non-orthodox dichotomy in
elite sports medicine
The overarching aim of this paper was to investigate how ther-
apeutic decisions are made, reasoned and enacted in a context where
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multiple healing systems are drawn from to manage injury. Our em-
pirical data highlight the porous boundaries between CAM and bio-
medicine in the practice of elite sports medicine where a wide range of
complementary, alternative or non-orthodox therapeutic modalities co-
exist and are blended together in various combinations. We have shown
how non-orthodox therapies are variously used instead of, alongside,
incorporated into, and/or hybridised with novel and established bio-
medical techniques and treatments in multiple ways (Gale, 2014; Dew
et al., 2014; Faulkner et al., 2017; McNamee et al., 2018; Cant and
Sharma, 1999; Parkin, 2013; Wiese et al, 2010). In our research, non-
orthodox therapies were viewed as credible therapeutic options for
injuries in multiple ways that cannot be easily accounted for by any
single model of the CAM/orthodox medicine relationship. We devel-
oped the concept of therapeutic landscape to advance beyond the ex-
isting theories of CAM/biomedicine relations.
The landscape of elite sports medicine is an atypical healthcare
environment where backgrounds, cultures, beliefs of medical practi-
tioners, coaches, managers and athlete-patients coalesce in practice.
Physicians working in sport have traditionally been innovative if not
idiosyncratic in their practices, but sports medicine practitioners in
many sports have now become more specialised and their occupational
positions at elite sports level have become more stable (Malcolm et al.,
2015), and hence their authority vis-à-vis managers and coaches has
increased. At the same time, they have to contend, as other medical
specialties do, with the advent of evidence-based medicine. Elite sport
is a high -pressured environment where the risk of injury is high as is
the pressure to recover from injury quickly, with the focus of inter-
vention on repairing impaired performance (Kimmerle et al., 2012) in
addition to healing the body. Elite sport medicine is also a therapeutic
landscape characterised by clinical uncertainty in many injuries, where,
as previous studies have shown, alternative approaches to injury
management can flourish (Malcolm, 2009). Reflecting on our data, we
can identify several aspects of the sports medicine landscape as a niche
therapeutic space that are central to creating the underlying conditions
of possibility for heterogeneous non-orthodox therapy utilisation. We
summarise these as ‘opportunity’, ‘variegation’, and ‘flexible control’.
In terms of opportunity, our data illustrate that elite sports medicine
can certainly be viewed as a privileged space where practitioners have
opportunity to acquire knowledge about a wide range of non-orthodox
therapies and practices, which is part and parcel of the globally net-
worked world they inhabit. Clubs and teams with high levels of fi-
nancial capital have access to the global healthcare market, with an
ever-growing assortment of technologies, tools and practitioners at
their disposal: cross-border health travel is common, and procurement
of international services is standard. Indeed, this is made even more
possible by the lack of regulation for most ‘CAM’ therapies and in some
cases, the minimal training required to become a licensed practitioner.
We found a high level of heterogeneity in the adoption and rejection of
non-orthodox therapies as well as in patterns of use and methods of
administration. Personal and professional networks are a powerful
mediator of healthcare (Nixon, 1993; Faulkner et al., 2017; McNamee
et al., 2018) facilitating access to novel therapies and techniques and
‘guru’ practitioners. This heterogeneity is reflected in the relative ab-
sence of standard protocols for how non-orthodox therapies should be
assimilated, incorporated or mixed into therapeutic regimes when
compared to other areas of medicine such as cancer treatment (Broom
and Tovey, 2007).
A second key underlying condition shaping the therapeutic land-
scape is variegation. Widely regarded as an emerging specialism in the
UK, sports medicine attracts practitioners from a broad range of dif-
ferent professional disciplines. In the era of globalisation - seen in its
extreme form in elite sports - both medical teams and sports teams are
typically formed of individuals from different geographical and cultural
backgrounds, bringing together culturally diverse experiences, prac-
tices, systems of knowledge and ideas about what ‘conventional’ or
‘orthodox’ medicine is. Consequently, the organisation and culture of
medical teams can vary significantly both within and between sports,
and this can have significant impact on how injuries come to be man-
aged (Carter, 2010). Our data demonstrate how therapeutic decision -
making in these settings is often a collective endeavor. Rather than a
traditional hierarchical dyadic doctor –patient relationship where a
medical doctor is responsible for therapeutic decisions, the elite sports
medicine context sees decisions made by medical teams that can com-
prise a variety of individuals including specialised sports physicians,
medical doctors, physiotherapists and surgeons. The variable social
organisation of sports medicine and treatment cultures operating within
particular sports and specific teams or clubs clearly has an influential
role, enabling and normalising the use of particular non-orthodox
therapies in these settings (Bundon and Hurd Clarke, 2014). We found
micro-cultures or ‘communities of practice’ (Wenger, 1998) within
sports clubs or teams bound by their shared interest and expertise,
engaging in a process of collective learning, sharing information and a
repertoire of practices, and this shaped the use of nonorthodox (as well
as orthodox) practices.
Additionally, we have observed the litany of other voices in ther-
apeutic decision-making, including those of mangers, agents, coaches,
sponsors, non-medical trainers and sports scientists. Our data indicate
that the athlete–patient, and in particular, their views and belief sys-
tems, are central to the decision making process. This diversity un-
derpins a requirement for negotiation in sports medicine and can result
in ongoing tensions over therapeutic decisions between different groups
of health care providers (Theberge, 2008; Faulkner et al., 2017) and
their patients. These conceptual tensions were revealed in practice in
what we have described as therapeutic reasoning, where discussions
around the legitimacy, or biological efficacy, of particular non-orthodox
therapies drew on assessments of their scientific evidence base. It is
interesting to note the absence from our participants' accounts of any
attention to the formal state regulation of non-orthodox therapies. In-
stead of legitimacy provided by such regulation, we see recourse to the
softer standards of ‘EBM’-style evidence, clinical experience and testi-
mony of others in their local and wider networks as the form of legit-
imation that matters – to some extent – to practitioners in elite sports
medicine.
The third element shaping the use/non-use of non-orthodox therapy
in the therapeutic landscape that we have illustrated, we refer to as
flexible control. For non-orthodox therapies to become a credible
therapeutic option in treating elite athletes, sports physicians had to be
flexible in their therapeutic approach, that is open to considering
therapies falling outside their disciplinary norms, experiential knowl-
edge and understanding. This flexibility sometimes encompassed an
avowed belief in subjective psychological benefits of non-orthodox
therapies. In addition, some of the sports physicians we spoke to al-
luded to how they might endorse the use of these therapies, even if they
did not accept their objective utility. In these instances, non-orthodox
therapies were thought of as harmless or even akin to placebo therapies
that made patients feel better. Further, our data show how CAM
therapies were often used as mechanisms of control over the ther-
apeutic relationship, preventing athlete-patients seeking alternative
therapies from elsewhere as global consumers of medicine (Ning,
2013).
In terms of therapeutic reasoning, we can see how biomedicine re-
tains its conceptual hegemony as the dominant form of healing
knowledge, and ‘scientific evidence’ – or lack thereof - is used to divide
‘legitimate’ therapies from alternatives, meaning that CAM therapies
can be othered in relation to biomedicine. This view, however, was not
always shared across the sample. Whilst some rejected the idea of using
a particular non-orthodox therapy on the grounds of lack of scientific
evidence for its utility, others did not. Our data show how sports
medicine practitioners can subject non-orthodox therapies to clinical
tests, trials and studies in their attempts to build scientific and clinical
evidence bases for particular therapies and align their use with a sci-
entific paradigm. Consequently, this leads to considerable blurring of
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the conceptual boundaries between biomedicine and other forms of
healing (Polich et al., 2010) across this particular landscape.
Nevertheless, our data show how therapeutic reasoning does not
always hinge on scientific evidence, exhibiting greater complexity than
that in practice. For example, we see how other forms of evidence or
‘evidentiality’ (Faulkner, 2009), such as the testimony of others are
given importance in therapeutic reasoning of sports medicine practi-
tioners, meaning that there is space for alternative epistemologies of
healing to exist alongside biomedicine. Thus, our findings align with
Malcom (2009) study of the case of concussion management where he
argues that “medically based diagnostic criteria and treatment guide-
lines are replaced by understanding and definitions … dominant in the
sports subculture” (2009; 191). Our findings here also cohere with
Willis and White’s (2017) work on the politico-legal status of CAMs in
Australia to some extent. They suggest that clinical legitimacy – so
patients reporting they feel better – can bear more weight than EBM
style ‘evidence’ on decisions around the legitimacy of particular
therapies, which is often absent or lacking. While our data does not
suggest replacement of one type of legitimacy for another, it does, like
Willis and White's earlier observations, evidence the importance given
to clinical judgement in clinical practice and the mixed role that EBM
often plays in this process.
In summary, our data show how within the therapeutic landscape of
elite sports medicine, therapeutic decision–making, reasoning and
practice are medically, culturally and biographically shaped. We argue
that the contemporary forms of CAM use within sports medicine are
multiple, and characterised by complexity, heterogeneity, contingency
and contestation.
5. Conclusion
Much theorising of medical pluralism, strangely perhaps given so-
ciology's typical concern for ‘alternatives’, grassroots movements and so
on, has taken a ‘top-down’ perspective based around vantage points of
the state and Western biomedical dominance. More particularly, al-
though there is a large literature in both anthropology and sociology on
medical pluralism, apart from studies focusing on the co-existence of
different modalities in given populations, other main concerns have
been on socio-demographics of populations accessing ‘alternative’
medicine, on general populations'/patients' everyday medical practices,
and the role of state regulation (Cant, 2004). In comparison, there are
few studies of the complex details of therapeutic decision-making,
therapeutic reasoning and therapeutic practice in settings and amongst
users and patients where a plurality of therapies is available, nor
amongst specific therapy user groups. Hence, contrary to the main-
stream sociological approaches noted above, our study takes the van-
tage point of the therapeutic decision-makers set within wider the
therapeutic landscapes they inhabit.
In conclusion, our analysis has shown how the dominant conceptual
tools we have to hand offer only a partial explanation of contemporary
CAM practices, centred on theorising relationships between biomedi-
cine and others. While the conceptual typology of pluralism, integration
and diversity/hybridisation captures the spectrum of CAM/orthodox
relations, it does not engage with the dynamics of nonorthodox medi-
cine use that we have illustrated. Thus, we argue that the typology of
orthodox/nonorthodox relations should not be seen dichotomously but
rather as a flexible, dynamic heuristic rather than as a categorisation
tool for static institutional relationships. We have developed the con-
cept of the ‘therapeutic landscape’ to enable us to take into account the
complex dynamics of clinical practice. We suggest that in order to gain
a more complete view of contemporary CAM practices, a wider con-
ceptual framework such as this is required to account for how patients,
professionals, knowledge, practices, techniques and technologies,
global networks and communities of practice come together and in-
teract in a specific locale and how this shifts as one or more of these
elements change. We also suggest that future theorisation of medical
pluralism should move beyond the dichotomy of ‘non-orthodox’ defined
in contrast to orthodox Western biomedicine, and embrace the diver-
sities of practices, power relations and institutional setting that we have
explored here.
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